News
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
The NHS will offer innovative cancer vaccines to individuals suffering from head and neck tumours as part of an expanded ...
“Stratus,” originally known as Variant XFG, is the second most prominent strain of COVID in the United States. According to ...
The suspected gunman in the attack that killed a police officer near the Emory University campus and the CDC's headquarters ...
The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.
The rapid rise of the SARS-CoV-2 variant XFG this summer could make it the dominant strain by the start of the fall COVID ...
26 April 2024 New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth ...
GSK said it will receive $370 million as part of the U.S. patent settlement involving CureVac and BioNTech over mRNA-based COVID-19 vaccines, The Wall Street Journal reported Aug. 8. Under the deal, ...
"Imagine defunding penicillin research in 1943 because of rare reactions. Absurd, right?" Dr. Jerome Adams wrote on X.
The complex settlement, which hands payouts and royalties to CureVac and partner GSK, comes as BioNTech is inching toward an ...
The pound rose to USD1.3450 late on Friday afternoon in London, compared to USD1.3412 at the equities close on Thursday. The euro traded at USD1.1666, higher against USD1.1631. Against the yen, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results